More recently, using ex vivo new generation-sequencing, Klarenbeek and coworkers [23] reported on the stability of the repertoire of anti-viral CD8 T cell responses to CMV and EBV in renal transplanted recipients by demonstrating that nearly all virus-specific clonotypes appearing during the acute phase of infection were maintained over time. This evidence concerns the gene CD8A and infection.